Health ❯ Healthcare ❯ Clinical Trials

Phase I Trials

Patient Outcomes Drug Efficacy Vaccine Trials AMPLIFY-201 Trial H5N1 Vaccine Trials Phase II Trials PDE3/4 Inhibitors Dopaminergic Neuron Transplantation Randomized Controlled Trials Ovarian Cancer Trials

First-in-Human SynKIR-110 Shows Safe Profile and Early Activity in Solid Tumors

The NK-inspired multi-chain receptor aims to curb T cell exhaustion by separating target sensing from activation.

Phase I Intranasal H5N1 Vaccine Shows Safety and Broad Immune Response

Mayo Clinic Stem Cell Trial Shows Early Gains for Dialysis Access

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

Cytokine-Enhanced CAR T Cell Therapy Achieves Breakthrough Results in Lymphoma

Breakthrough Cell Therapy IMA203 Achieves Durable Responses in Solid Tumors

Experimental Vaccine Keeps Kidney Cancer Patients Cancer-Free for Three Years

Glioblastoma Treatment Response Accurately Modeled Using Patient-Derived Organoids

Experimental mRNA Vaccine Shows Promise in Early Cancer Trials